Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Swisher

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Gynecologic Oncology|January 24, 2012
Hereditary ovarian cancer: beyond the usual suspectsKathryn P Pennington, Elizabeth M Swisher
Obstetrics and Gynecology|September 9, 2016
Spontaneous Twin Pregnancy After Oophoropexy and Pelvic Radiation for Rectal CancerKaitlyn Wald, Tom Easterling, Elizabeth M Swisher
Cancer Science|January 6, 2011
Secondary mutations of BRCA1/2 and drug resistanceKiranjit K Dhillon, Elizabeth M Swisher, Toshiyasu Taniguchi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
Poly (ADP-ribose) polymerase inhibitors: recent advances and future developmentClare L Scott, Elizabeth M Swisher, Scott H Kaufmann
Trends in Cancer|November 10, 2017
Doubling Down on BRCA-Mutated CancerAndrea E Wahner Hendrickson, Scott H Kaufmann, Elizabeth M Swisher
Genome Medicine|May 26, 2025
DNA repair and the contribution to chemotherapy resistanceKsenija Nesic, Phoebe Parker, Elizabeth M Swisher, et al.
Gynecologic Oncology Reports|June 16, 2015
Premalignant alterations in breast and endometrium associated with a PTEN mutation in a woman with Cowden syndrome: implications for preventive careChristopher B Morse, Rochelle L Garcia, Kristine E Calhoun, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 25, 2007
Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: when is a full staging procedure unnecessary?Kimberly H Allison, Elizabeth M Swisher, Katrina M Kerkering, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
Biomarkers of Response and Resistance to DNA Repair Targeted TherapiesElizabeth H Stover, Panagiotis A Konstantinopoulos, Ursula A Matulonis, et al.
Cancers|December 24, 2021
PARP Inhibitors and Myeloid Neoplasms: A Double-Edged SwordClifford M Csizmar, Antoine N Saliba, Elizabeth M Swisher, et al.
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Gynecologic Oncology|January 24, 2012
Hereditary ovarian cancer: beyond the usual suspectsKathryn P Pennington, Elizabeth M Swisher
Obstetrics and Gynecology|September 9, 2016
Spontaneous Twin Pregnancy After Oophoropexy and Pelvic Radiation for Rectal CancerKaitlyn Wald, Tom Easterling, Elizabeth M Swisher
Cancer Science|January 6, 2011
Secondary mutations of BRCA1/2 and drug resistanceKiranjit K Dhillon, Elizabeth M Swisher, Toshiyasu Taniguchi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
Poly (ADP-ribose) polymerase inhibitors: recent advances and future developmentClare L Scott, Elizabeth M Swisher, Scott H Kaufmann
Trends in Cancer|November 10, 2017
Doubling Down on BRCA-Mutated CancerAndrea E Wahner Hendrickson, Scott H Kaufmann, Elizabeth M Swisher
Genome Medicine|May 26, 2025
DNA repair and the contribution to chemotherapy resistanceKsenija Nesic, Phoebe Parker, Elizabeth M Swisher, et al.
Gynecologic Oncology Reports|June 16, 2015
Premalignant alterations in breast and endometrium associated with a PTEN mutation in a woman with Cowden syndrome: implications for preventive careChristopher B Morse, Rochelle L Garcia, Kristine E Calhoun, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 25, 2007
Defining an appropriate threshold for the diagnosis of serous borderline tumor of the ovary: when is a full staging procedure unnecessary?Kimberly H Allison, Elizabeth M Swisher, Katrina M Kerkering, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2016
Biomarkers of Response and Resistance to DNA Repair Targeted TherapiesElizabeth H Stover, Panagiotis A Konstantinopoulos, Ursula A Matulonis, et al.
Cancers|December 24, 2021
PARP Inhibitors and Myeloid Neoplasms: A Double-Edged SwordClifford M Csizmar, Antoine N Saliba, Elizabeth M Swisher, et al.
Pageof 20